Purchase this article with an account.
Katsuya Yamazoe, Satoru Yoshida, Shin Hatou, Miyuki Yasuda, Emi Inagaki, Yoko Ogawa, Kazuo Tsubota, Shigeto Shimmura; Development of a transgenic mouse with R124H human TGFBI mutation associated with Avellino corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2525.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To investigate the phenotype and predisposing factors of an Avellino corneal dystrophy transgenic mouse model.
Human TGFBI cDNA with R124H mutation was used to make a transgenic mouse expressing human protein (TGFBIR124H mouse). Reverse transcription PCR (RT-PCR) was performed to analyze TGFBIR124H expression. A total of 187 mice including 17 homozygotes, 85 heterozygotes and 85 wild-type mice were examined for phenotype. Affected mice were also examined by histology, immunohistochemistry and electron microcopy.
RT-PCR confirmed the expression of TGFBIR124H in homozygous mice. Corneal opacity defined as granular and lattice deposits was observed in 52.9% of homozygotes, 20.0% of heterozygotes. The incidence of corneal opacity was significantly higher in homozygotes than in heterozygotes. Histology of affected mice was similar to histology of human Avellino dystrophy. Lesions were Congo red and Masson Trichrome positive, and were observed as a deposit of amorphous material by electron microscopy. The incidence of corneal opacity was higher in aged mice in each group.
We established an Avellino dystrophy mouse model caused by R124H mutation of human TGFBI.
This PDF is available to Subscribers Only